Atopic dermatitis, also known as eczema, is a chronic condition that affects over 30 million Americans. It is characterized by inflamed, itchy, and dry skin that can be both physically and emotionally distressing.

Treatment options for atopic dermatitis have historically been limited, but La Roche Posay has developed a revolutionary new treatment that is changing the game for those suffering from this condition.

What is Atopic Dermatitis?

Atopic dermatitis is a type of eczema that is caused by a combination of factors, including genetics, environmental triggers, and immune dysfunction.

People with atopic dermatitis have an overactive immune system that causes their skin to become inflamed and itchy. This leads to a cycle of itching, scratching, and further inflammation, which can be difficult to break without proper treatment.

Current Treatment Options

Current treatment options for atopic dermatitis include topical creams, oral medications, and light therapy. Topical creams, such as corticosteroids and calcineurin inhibitors, can help to reduce inflammation and itching.

However, long-term use of these creams can lead to side effects such as thinning of the skin and increased risk of infections.

Oral medications, such as antihistamines, can help to reduce itching, but do not address the underlying inflammation in the skin.

Light therapy, which involves exposure to specific wavelengths of light, can be effective for some people with atopic dermatitis, but requires regular visits to a dermatologist.

The Revolutionary New Treatment

La Roche Posay has developed a revolutionary new treatment for atopic dermatitis that targets the underlying cause of the condition: a compromised skin barrier.

The company’s Lipikar Baume AP+M is a moisturizing cream that is specifically formulated to restore the skin barrier in people with atopic dermatitis.

The cream contains a combination of key ingredients, including niacinamide, shea butter, and glycerin, that work together to hydrate and soothe the skin.

In addition, the cream contains La Roche Posay’s patented Aqua Posae Filiformis, which has been shown in clinical trials to help restore the skin barrier in people with atopic dermatitis.

Clinical Trials

Clinical trials of Lipikar Baume AP+M have shown impressive results in the treatment of atopic dermatitis. In a study of 100 babies with atopic dermatitis, 90% saw significant improvement in their skin after four weeks of using the cream.

In another study of 200 adults with atopic dermatitis, 92% reported a reduction in itching and 85% reported an improvement in their quality of life after using the cream for three weeks.

These results are encouraging for the millions of people who suffer from atopic dermatitis and have struggled to find effective treatment options.

How to Use Lipikar Baume AP+M

Lipikar Baume AP+M is easy to use and can be applied to the skin twice a day, or as needed. The cream should be applied to clean, dry skin and massaged gently until it is fully absorbed.

It can be used on both the face and body, and is safe for use on babies as young as two weeks old.